Avesthagen

About:

Avesthagen pioneers the convergence between food, pharma and population genetics leading to predictive preventive personalized healthcare.

Website: http://www.avesthagen.com

Twitter/X: Avesthagen

Top Investors: New York Life Investment Management

Description:

Avesthagen is a life science company pioneering the convergence between Food, Pharma and Population Genetics leading to Predictive Preventive Personalized Healthcare. The business model of Avesthagen is to combine IP & product development through in-house research and collaborations. Avesthagen has built and continues to build an integrated, systems biology approach of capabilities, products, infrastructure and technology that allows for and facilitates ‘cross talk’ between numerous disciplines, leading to unique and innovative solutions. They employ 450 people worldwide and are headquartered in Bangalore, India.

Total Funding Amount:

$5.53M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Bangalore, Karnataka, India

Founded Date:

1998-01-01

Contact Email:

info(AT)avesthagen.com

Founders:

Villoo Patell

Number of Employees:

51-100

Last Funding Date:

2007-05-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai